Jin Yang Pharmaceutical Co., Ltd. (KOSDAQ:007370)
South Korea
· Delayed Price · Currency is KRW 4,940.00
+60.00 (1.23%)
At close: Apr 29, 2026
Jin Yang Pharmaceutical Cash Flow Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Net Income | 22,287 | 29,694 | 12,659 | 12,308 | 9,538 | Upgrade
|
| Depreciation & Amortization | 2,409 | 2,024 | 2,655 | 2,291 | 2,154 | Upgrade
|
| Loss (Gain) From Sale of Assets | -31.33 | 77.14 | -0.86 | -24.9 | -9.53 | Upgrade
|
| Asset Writedown & Restructuring Costs | -29,000 | -24,919 | -2,263 | -3,556 | -1,451 | Upgrade
|
| Loss (Gain) From Sale of Investments | 112.38 | 621.53 | 9.65 | 97.96 | 13.48 | Upgrade
|
| Provision & Write-off of Bad Debts | 1,630 | -1,449 | 1,470 | 50.09 | -1,383 | Upgrade
|
| Other Operating Activities | 6,216 | 5,682 | 1,122 | 2,567 | 3,235 | Upgrade
|
| Change in Accounts Receivable | 1,446 | -2,755 | -2,754 | -918.28 | 132.24 | Upgrade
|
| Change in Inventory | -999.18 | 2,457 | -2,056 | -6,332 | -1,180 | Upgrade
|
| Change in Accounts Payable | -1,178 | 1,862 | -756.94 | 2,227 | -1,827 | Upgrade
|
| Change in Unearned Revenue | -40.5 | -30.13 | - | - | - | Upgrade
|
| Change in Other Net Operating Assets | -1,385 | -473.3 | -1,551 | -1,263 | -7,251 | Upgrade
|
| Operating Cash Flow | 1,465 | 12,792 | 8,534 | 7,448 | 1,971 | Upgrade
|
| Operating Cash Flow Growth | -88.55% | 49.91% | 14.58% | 277.96% | -68.44% | Upgrade
|
| Capital Expenditures | -4,266 | -90,060 | -682.28 | -3,218 | -2,516 | Upgrade
|
| Sale of Property, Plant & Equipment | 1.36 | 0.91 | 0.91 | 25.09 | 9.55 | Upgrade
|
| Sale (Purchase) of Intangibles | -1,563 | -397.44 | -851.25 | -1,423 | -207.08 | Upgrade
|
| Investment in Securities | -246.18 | 4,247 | 4,775 | -7,950 | -1,528 | Upgrade
|
| Other Investing Activities | -163.96 | -66.35 | -7 | -266.8 | -36.19 | Upgrade
|
| Investing Cash Flow | -6,385 | -86,276 | 3,236 | -12,833 | -4,278 | Upgrade
|
| Short-Term Debt Issued | 9,462 | - | - | - | - | Upgrade
|
| Long-Term Debt Issued | 5,585 | 76,500 | - | - | 16,000 | Upgrade
|
| Total Debt Issued | 15,047 | 76,500 | - | - | 16,000 | Upgrade
|
| Short-Term Debt Repaid | -9,462 | - | - | - | -6,000 | Upgrade
|
| Long-Term Debt Repaid | -1,480 | -4,756 | -5,678 | -189.12 | -129.92 | Upgrade
|
| Total Debt Repaid | -10,942 | -4,756 | -5,678 | -189.12 | -6,130 | Upgrade
|
| Net Debt Issued (Repaid) | 4,105 | 71,744 | -5,678 | -189.12 | 9,870 | Upgrade
|
| Issuance of Common Stock | 3,124 | - | - | - | - | Upgrade
|
| Repurchase of Common Stock | - | - | - | -2,574 | - | Upgrade
|
| Dividends Paid | -1,714 | -1,619 | -1,616 | -1,118 | -1,118 | Upgrade
|
| Other Financing Activities | -170 | 20 | -110 | -1,700 | 100 | Upgrade
|
| Financing Cash Flow | 5,344 | 70,145 | -7,404 | -5,581 | 8,852 | Upgrade
|
| Foreign Exchange Rate Adjustments | 0.03 | - | -0.68 | - | - | Upgrade
|
| Miscellaneous Cash Flow Adjustments | - | 0 | - | - | - | Upgrade
|
| Net Cash Flow | 423.93 | -3,338 | 4,365 | -10,966 | 6,544 | Upgrade
|
| Free Cash Flow | -2,801 | -77,268 | 7,851 | 4,230 | -545.86 | Upgrade
|
| Free Cash Flow Growth | - | - | 85.62% | - | - | Upgrade
|
| Free Cash Flow Margin | -2.32% | -68.18% | 8.34% | 5.55% | -0.87% | Upgrade
|
| Free Cash Flow Per Share | - | -6265.96 | 629.22 | 314.65 | -47.82 | Upgrade
|
| Cash Interest Paid | 2,160 | 1,132 | 19.46 | 14.53 | 87.13 | Upgrade
|
| Cash Income Tax Paid | 1,850 | 2,339 | 172.1 | 1,130 | 430.46 | Upgrade
|
| Levered Free Cash Flow | -6,198 | -80,264 | 2,805 | -1,894 | -4,291 | Upgrade
|
| Unlevered Free Cash Flow | -4,765 | -79,105 | 3,664 | -1,091 | -4,161 | Upgrade
|
| Change in Working Capital | -2,157 | 1,061 | -7,118 | -6,286 | -10,125 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.